Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Goddard

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|February 10, 2009
Ambrisentan and its role in the management of pulmonary arterial hypertensionIain M Macintyre, Neeraj Dhaun, Jane Goddard, et al.
Trends in Pharmacological Sciences|October 24, 2007
Selective and mixed endothelin receptor antagonism in cardiovascular diseaseNeeraj Dhaun, David M Pollock, Jane Goddard, et al.
American Journal of Physiology. Renal Physiology|September 15, 2007
Fractional urinary excretion of endothelin-1 is reduced by acute ETB receptor blockadeJane Goddard, Neil R Johnston, Allan D Cumming, et al.
Injury|September 5, 2009
Acute renal dysfunction following hip fractureSimon J Bennet, Olivia M B Berry, Jane Goddard, et al.
Diabetes Care|June 1, 2012
Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidityPajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, et al.
Hypertension (Dallas, Tex. : 1979)|April 21, 2010
Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy menIain M MacIntyre, Neeraj Dhaun, Pajaree Lilitkarntakul, et al.
Life Sciences|March 13, 2012
What is the best method of proteinuria measurement in clinical trials of endothelin receptor antagonists?Jonathan D Towler, Neeraj Dhaun, Margaret MacDougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 9, 2007
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney diseaseNeeraj Dhaun, Charles J Ferro, Anthony P Davenport, et al.
Hypertension (Dallas, Tex. : 1979)|August 6, 2008
Role of endothelin-1 in clinical hypertension: 20 years onNeeraj Dhaun, Jane Goddard, Donald E Kohan, et al.
Hypertension (Dallas, Tex. : 1979)|November 10, 2010
Renal dysfunction does not affect the peripheral-to-central arterial pressure transfer functionRupert A Payne, Pajaree Lilitkarntakul, Neeraj Dhaun, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Drugs of Today (Barcelona, Spain : 1998)|February 10, 2009
Ambrisentan and its role in the management of pulmonary arterial hypertensionIain M Macintyre, Neeraj Dhaun, Jane Goddard, et al.
Trends in Pharmacological Sciences|October 24, 2007
Selective and mixed endothelin receptor antagonism in cardiovascular diseaseNeeraj Dhaun, David M Pollock, Jane Goddard, et al.
American Journal of Physiology. Renal Physiology|September 15, 2007
Fractional urinary excretion of endothelin-1 is reduced by acute ETB receptor blockadeJane Goddard, Neil R Johnston, Allan D Cumming, et al.
Injury|September 5, 2009
Acute renal dysfunction following hip fractureSimon J Bennet, Olivia M B Berry, Jane Goddard, et al.
Diabetes Care|June 1, 2012
Risk factors for metabolic syndrome independently predict arterial stiffness and endothelial dysfunction in patients with chronic kidney disease and minimal comorbidityPajaree Lilitkarntakul, Neeraj Dhaun, Vanessa Melville, et al.
Hypertension (Dallas, Tex. : 1979)|April 21, 2010
Greater functional ETB receptor antagonism with bosentan than sitaxsentan in healthy menIain M MacIntyre, Neeraj Dhaun, Pajaree Lilitkarntakul, et al.
Life Sciences|March 13, 2012
What is the best method of proteinuria measurement in clinical trials of endothelin receptor antagonists?Jonathan D Towler, Neeraj Dhaun, Margaret MacDougall, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 9, 2007
Haemodynamic and renal effects of endothelin receptor antagonism in patients with chronic kidney diseaseNeeraj Dhaun, Charles J Ferro, Anthony P Davenport, et al.
Hypertension (Dallas, Tex. : 1979)|August 6, 2008
Role of endothelin-1 in clinical hypertension: 20 years onNeeraj Dhaun, Jane Goddard, Donald E Kohan, et al.
Hypertension (Dallas, Tex. : 1979)|November 10, 2010
Renal dysfunction does not affect the peripheral-to-central arterial pressure transfer functionRupert A Payne, Pajaree Lilitkarntakul, Neeraj Dhaun, et al.
Pageof 4